Ram Kamineni

Chief Tech/Sci/R&D Officer en KRYSTAL BIOTECH, INC. .

Health Technology

Perfil

Ram Kamineni is currently working as the Senior VP-CMC & Technical Operations at Krystal Biotech, Inc. Prior to this role, he worked as the Chief Operating Officer at KVK-Tech, Inc.

Cargos activos de Ram Kamineni

Empresas	Cargo	Inicio
KRYSTAL BIOTECH, INC.	Chief Tech/Sci/R&D Officer	01/07/2022

Todos los cargos activos de Ram Kamineni

Antiguos cargos conocidos de Ram Kamineni.

Empresas	Cargo	Fin
KVK-Tech, Inc. KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso.	Chief Operating Officer	01/10/2021

Ver el detalle de la experiencia de Ram Kamineni.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ram Kamineni.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
KRYSTAL BIOTECH, INC.	Health Technology

Empresas privadas	1
KVK-Tech, Inc. KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso.	Health Technology